Mechanisms of action of vitamin D: Recent findings and new questions

Journal of Medicinal Food

Volumn 9, Issue 2, 2006, Pages 135-137

  Lipkin, Martin ^a,b   Lamprecht, Sergio A ^a  

^a STRANG CANCER PREVENTION CENTER   (United States)

^b ROCKEFELLER UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; CALCIFEDIOL; CELL NUCLEUS RECEPTOR; CYCLIN DEPENDENT KINASE INHIBITOR 1; HISTONE ACETYLTRANSFERASE PCAF; HISTONE H3; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN P21; PROTEIN P53; RETINOID X RECEPTOR; STEROID RECEPTOR COACTIVATOR 1; T CELL FACTOR PROTEIN; VITAMIN D; VITAMIN D RECEPTOR; WNT PROTEIN;

CHROMATIN STRUCTURE; DRUG MECHANISM; DRUG RECEPTOR BINDING; EDITORIAL; GENE LOCUS; HUMAN; OSTEOBLAST; PRIORITY JOURNAL; PROMOTER REGION; RISK ASSESSMENT; SIGNAL TRANSDUCTION; VITAMIN BLOOD LEVEL; VITAMIN D RESPONSIVE ELEMENT; VITAMIN INTAKE; VITAMIN SUPPLEMENTATION;

ADULT; AGED; ANTICARCINOGENIC AGENTS; CALCIFEDIOL; DIET; HUMANS; MIDDLE AGED; NF-KAPPA B; POLYMORPHISM, GENETIC; RECEPTORS, CALCITRIOL; RETINOID X RECEPTORS; VITAMIN D;

EID: 33745865226     PISSN: 1096620X     EISSN: None     Source Type: Journal    
DOI: 10.1089/jmf.2006.9.135     Document Type: Editorial

References (17)

1. Nagpal S, Na S, Rathnachalam R: Noncalcemic actions of vitamin D receptor ligands. Endocr Rev 2005;26:662-687.
2. Ebert R, Schutze N, Adamski J, Jakob F: Vitamin D signaling is modulated on multiple levels in health and disease. Mol Cell Endocrinol 2006;248:149-159. Epub 2006 Jan 9.
3. Garland CF, Garland FC, Gorham ED, et al.: The role of vitamin D in cancer prevention. Am J Public Health 2006;96:252-261.
4. Cross HS, Lipkin M, Kallay E: Nutrients regulate the colonic vitamin D system in mice: relevance for human colon malignancy. J Nutr 2006;136:561-564.
5. Giovannucci E: The epidemiology of vitamin D and colorectal cancer: recent findings. Curr Opin Gastroenterol 2006;22:24-29.
6. nd ed. (Feldman D, Wesley Pike J, Glorieux FH, eds.), Elsevier Academic Press, London, 2005, pp. 167-191.
7. nd ed. (Feldman D, Wesley Pike J, Glorieux FH, eds.), Elsevier Academic Press, London, 2005, pp. 263-277.
8. Dusso AS, Brown AJ, Slatopolsky E: Vitamin D. Am J Physiol Renal Physiol 2005;289:8-28.
9. Kim S, Shevde NK, Pike JW: 1,25-Dihydroxyvitamin D3 stimulates cyclic vitamin D receptor/retinoid X receptor DNA-binding, co-activator recruitment, and histone acetylation in intact osteoblasts. J Bone Miner Res 2005;20:305-317.
10. Uitterlinden AG, Fang Y, van Meurs JBJ, et al.: Genetics and biology of vitamin D receptor polymorphisms. Gene 2004;338:143-156.
11. Prosser DE, Jones G: Enzymes involved in the activation and inactivation of vitamin D. Trends Biochem Sci 2004;29:664-673.
12. Lamprecht SA, Lipkin M: Chemoprevention of colon cancer by calcium, vitamin D and folate: molecular mechanisms. Nat Rev Cancer 2003;3:601-614.
13. 3 receptor. Nucleic Acids Res 2006;34:543-554.
14. Sun J, Kong J, Duan Y, et al.: Increased NF-κB activity in fibroblasts lacking the vitamin D receptor. Am J Physiol Endocrinol Metab 2006 Feb 28; [Epub ahead of print].
15. Cohen-Lahav M, Shany S, Tobvin D, et al.: Vitamin D decreases NFκB activity by increasing IκBα levels. Nephrol Dial Transplant 2006;21:889-897.
16. Mulholland DJ, Dedhar S, Coetzee GA, Nelson CC: Interaction of nuclear receptors with the Wnt/beta-catenin/Tcf signaling axis: Wnt you like to know? Endocr Rev 2005;26:898-915.
17. Jenuwein T, Allis CD: Translating the histone code. Science 2001;293:1074-1080.